Search results
Drew Weissman, MD, PhD, is a world-renowned physician and researcher at Penn Medicine, best known for his contributions to RNA biology and the COVID-19 vaccines. Weissman and Katalin Karikó, PhD, were jointly awarded the 2023 Nobel Prize in Medicine for their discoveries that enabled the modified mRNA technology being used in Pfizer-BioNTech ...
Drew Weissman (born September 7, 1959) is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Dr. Weissman is a renowned physician and researcher who invented the modified mRNA technology for COVID-19 vaccines. He and his team are also working on other mRNA vaccines and therapeutics for coronaviruses, flu, herpes, and cancer.
May 13, 2024 · Drew Weissman (born September 7, 1959, Lexington, Massachusetts, U.S.) is an American immunologist whose groundbreaking research into RNA (ribonucleic acid) opened the path to the development of RNA therapeutics, most notably the generation of messenger RNA (mRNA) vaccines.
- Kara Rogers
Oct 2, 2023 · Physician and scientist Drew Weissman, who earned both an MD and a PhD at Boston University, and his research collaborator, Katalin Karikó, have won the 2023 Nobel Prize in Physiology or Medicine for their pioneering work developing the technology that powers the Pfizer-BioNTech and Moderna COVID-19 vaccines, the Nobel committee announced on ...
Dec 11, 2020 · Friday, December 11, 2020—Drew Weissman, MD, PhD, an infectious disease expert at Penn Medicine, has been studying RNA for use in vaccines for over 15 years. He has dreamed about the seemingly endless possibilities of treating diseases with custom-made mRNA.
Jan 18, 2024 · 2023 Nobel Prize winner Drew Weissman, MD, PhD, reflects on the value of basic science research. The laureate discusses the groundbreaking work that led to COVID-19 vaccines, why he persisted with RNA research despite repeated setbacks, and the value of scientists working in-person. By Patrick Boyle, Senior Staff Writer.
Related searches
